Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade. Khan I, Rodriguez-Brotons A, Bhattacharjee A, Bezrookove V, et al. J Clin Invest 2025 Jul 10:e185220. doi: 10.1172/JCI185220.

Read + Share

Amedeo Smart

Independent Medical Education

Khan I, Rodriguez-Brotons A, Bhattacharjee A, Bezrookove V, et al. Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade. J Clin Invest 2025 Jul 10:e185220. doi: 10.1172/JCI185220.
PMID: 40638246